BRCA familial risk assessment and genetic counselling
What it is
Risk assessment for a genetic breast cancer risk begins in the history. Within the triple assessment of a breast complaint, the family history asked for is breast ca, ovarian ca and other cancers, and it is asked because family history is itself a risk factor: especially first-degree female relatives, though only 2-4 times the risk, and probably because a direct genetic factor is involved in the development of breast cancer in about 5% of patients.
The named genes are:
- BRCA1 (#17), which links breast and ovarian cancer.
- BRCA2 (#11), which links breast cancer with other cancers including melanoma and colorectal, but not ovarian.
- TP53 and PTEN, listed on the same line of risk factors.
How it is treated
What a BRCA mutation changes is the screening and the surgery offered.
Screening is by group: average risk is a mammogram every 1-2 years from age 40, while the high-risk group of BRCA or a strong FH is MRI plus mammogram yearly from age 30. Prior chest radiation is its own group, starting at 25 y or 8 years post-radiation. MRI has this same place when a breast mass is assessed: it is used in the post-treated breast, where there is concern about multifocality or multicentre disease in a young patient, and in BRCA1 and 2.
On the surgical side, simple or total mastectomy is indicated for a large tumor, multiple tumors, patient choice, and BRCA mutation carriers, and immediate reconstruction may be added to it.
A family history of breast cancer also changes what is done with a benign lump: it is one of the indications for lumpectomy of a fibroadenoma, beside a size of 4 cm or more, an increase in size during follow-up ultrasound, a complex fibroadenoma, patient request and an age over 40 years.